We are live on ! Find out more
CLB icon

Core Laboratories

178 hedge funds and large institutions have $1.16B invested in Core Laboratories in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

296% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $255K

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

9% more funds holding

Funds holding: 164178 (+14)

2% more capital invested

Capital invested by funds: $1.13B → $1.16B (+$26.3M)

0.88% less ownership

Funds ownership: 104.51%103.64% (-0.88%)

15% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 66

Holders
178
Holders Change
+14
Holders Change %
+8.54%
% of All Funds
2.82%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
56
Reduced
66
Closed
8
Calls
$1.01M
Puts
$255K
Net Calls
+$755K
Net Calls Change
-$568K
Name Holding Trade Value Shares
Change
Change in
Stake
AI
1
Ariel Investments
Illinois
$218M -$13.9M -568,005 -6%
BlackRock
2
BlackRock
New York
$186M -$4.15M -169,185 -2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$129M -$1.89M -76,917 -1%
EARNEST Partners
4
EARNEST Partners
Georgia
$90.8M -$1.32M -53,826 -1%
BTW
5
Boston Trust Walden
Massachusetts
$54.7M +$1.94M +79,166 +4%
State Street
6
State Street
Massachusetts
$49.9M +$5.63M +229,583 +12%
FAM
7
Fred Alger Management
New York
$31.9M -$34.4M -1,401,417 -51%
CAM
8
Congress Asset Management
Massachusetts
$27M +$3.79M +154,608 +16%
Ameriprise
9
Ameriprise
Minnesota
$23.1M +$2.35M +95,949 +11%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$22.6M +$1.19M +48,636 +5%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$20.9M +$1.43M +58,408 +7%
DGI
12
Disciplined Growth Investors
Minnesota
$17.7M -$511K -20,808 -3%
VanEck Associates
13
VanEck Associates
New York
$17M +$165K +6,703 +1%
RA
14
Royce & Associates
New York
$16.5M +$1.78M +72,476 +12%
Morgan Stanley
15
Morgan Stanley
New York
$16.5M +$3.93M +160,139 +30%
Fisher Asset Management
16
Fisher Asset Management
Washington
$14.9M +$10.6M +430,756 +227%
Charles Schwab
17
Charles Schwab
California
$14.1M -$445K -18,121 -3%
Northern Trust
18
Northern Trust
Illinois
$12.9M +$82K +3,339 +0.6%
LP
19
LMR Partners
United Kingdom
$10.5M +$10.7M +437,154 New
Invesco
20
Invesco
Georgia
$10.5M +$2.16M +88,013 +25%
State Farm Mutual Automobile Insurance
21
State Farm Mutual Automobile Insurance
Illinois
$10.2M
Bank of New York Mellon
22
Bank of New York Mellon
New York
$8.79M -$866K -35,273 -9%
Envestnet Asset Management
23
Envestnet Asset Management
Illinois
$7.89M +$2.29M +93,354 +40%
Norges Bank
24
Norges Bank
Norway
$7.1M +$1.13M +46,187 +19%
WI
25
Wintrust Investments
Illinois
$6.81M -$1.73M -70,600 -20%

CLB Hedge Fund Activity: Q3 2023 in Review

178 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2023, worth a combined $1.16B — up 2.3% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CLB positions and 8 closed out — a net gain of 14 holders — while 56 added to existing stakes and 66 trimmed.

The largest buyer was LMR Partners, opening a new position worth an estimated $10.7M. The largest seller was Fred Alger Management, cutting an estimated $34.4M.

  • 178 institutional investors held Core Laboratories (CLB) as of Q3 2023, up from 164 in Q2 2023.
  • Funds reported $1.16B of Core Laboratories stock for Q3 2023, up 2.3% quarter-over-quarter.
  • 22 funds opened new Core Laboratories positions in Q3 2023 and 8 closed out, a net change of +14 holders.
  • The largest Core Laboratories buyer in Q3 2023 was LMR Partners, an estimated $10.7M added.
  • The largest Core Laboratories seller in Q3 2023 was Fred Alger Management, an estimated $34.4M sold.

Based on aggregated 13F filings for Q3 2023.